Dual treatment controls agitation in one dose, study says

11/7/2012 | MedWire News (U.K.)

Agitation control was achieved in 83% of advanced cancer patients with just the first dose of haloperidol plus midazolam without significant complications, according to a study in the American Journal of Hospice and Palliative Care. Portuguese researchers called the results encouraging because most patients "were controlled in 30 minutes or less."

View Full Article in:

MedWire News (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA